Gamma Investing LLC Apellis Pharmaceuticals, Inc. Transaction History
Gamma Investing LLC
- $1.01 Trillion
- Q3 2024
A detailed history of Gamma Investing LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 403 shares of APLS stock, worth $13,355. This represents 0.0% of its overall portfolio holdings.
Number of Shares
403
Previous 153
163.4%
Holding current value
$13,355
Previous $5.87 Million
98.04%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding APLS
# of Institutions
308Shares Held
115MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$516 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$394 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$368 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$325 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$192 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.64B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...